androstanolone stanolone also known dihydrotestosterone dht sold brand name andractim among others androgen anabolic steroid aas medication hormone used mainly treatment low testosterone levels also used treat breast development small penis compared testosterone androstanolone dht less likely aromatize estrogen therefore shows less pronounced estrogenic side effects gynecomastia water retention hand androstanolone dht show significant androgenic side effects acne hair loss prostate enlargement strong androgenic effects musclebuilding effects well relatively weak estrogenic typically given gel application skin also used ester injection side effects androstanolone include symptoms masculinization like acne increased hair growth voice changes increased sexual medication naturally occurring androgen anabolic steroid hence agonist androgen receptor ar biological target androgens like testosterone androstanolone discovered introduced medical use used mostly france drug used weightlifters increase performance due powerful androgenic medication controlled substance many countries nonmedical use generally androstanolone available pharmaceutical formulations medical use used mainly form androgen replacement therapy treatment male hypogonadism specifically approved indication certain however longer recommended purpose due biological differences testosterone lack estrogenic effects partial androgenic topical androstanolone useful treatment similarly androstanolone enanthate via intramuscular injection found effective treatment persistent pubertal medication also used topical gel treat small penis pre peripubertal boys mild partial androgen insensitivity androstanolone found effective treatment advanced breast cancer women although used high doses caused severe used microcrystalline aqueous suspension intramuscular shortly thereafter drostanolone propionate propionate developed use instead androstanolone due superior pharmacokinetics introduced indication united states europe early androstanolone used dose mg sublingually two three times per day androgen replacement therapy also anabolic dosage androstanolone androstanolone available hydroalcoholic gel given transdermally doses gday brand name medication previously available mg oral tablet mg llysine brand name lysinex mg sublingual tablet brand names anabolex anaprotin anabolene anaboleen medication also marketed form several androstanolone esters including androstanolone benzoate brand names ermaloneamp hermalone sarcosan androstanolone enanthate brand name anaboleen depot androstanolone propionate brand name pesomax androstanolone valerate brand name apeton provided oil solutions intramuscular injection regular adverse effects androstanolone similar aas include androgenic side effects like oily skin acne seborrhea increased facialbody hair growth scalp hair loss increased aggressiveness sex women androstanolone cause partially irreversible virilization instance voice deepening hirsutism clitoromegaly breast atrophy muscle hypertrophy well menstrual disturbances reversible men medication may also cause hypogonadism testicular atrophy reversible infertility sufficiently high androstanolone adverse effects cardiovascular system especially longterm administration high aas like androstanolone stimulate erythropoiesis red blood cell production increase hematocrit levels high dosages cause polycythemia overproduction red blood cells greatly increase risk thrombic events embolism unlike many aas androstanolone aromatized estrogens hence risk estrogenic side effects like gynecomastia fluid retention addition aas administered parenterally androstanolone risk theorized androstanolone may less risk benign prostatic hyperplasia prostate cancer testosterone aromatized relevant estrogens thought possibly necessary manifestation accordance androstanolone found increase prostate gland size conversely due lack aromatization estrogens androstanolone therapy androgen replacement may result decreased bone mineral density incomplete effects brain undesirable changes cholesterol androstanolone potent agonist ar affinity kd nm human ar higher testosterone kd dissociation rate androstanolone ar also slower androstanolone activation ar nm stronger testosterone bioassays androstanolone found potent upon intramuscular injection rats androstanolone potency unlike testosterone various aas androstanolone aromatized reason poses risk estrogenic side effects like gynecomastia addition androstanolone metabolized already reason potentiated socalled androgenic tissues like skin hair follicles prostate gland thereby improving ratio anabolic androgenic effects however androstanolone nonetheless described poor anabolic attributed high affinity substrate dehydrogenase highly expressed skeletal muscle inactivates androstanolone metabolite weak ar unlike androstanolone testosterone resistant metabolism similarly inactivated skeletal preceding reasons androstanolone described partial bioavailability androstanolone differs considerably depending route oral bioavailability low androstanolone considered ineffective oral however used orally described weak aas transdermal bioavailability androstanolone approximately bioavailability intramuscular injection hand complete doses topical androstanolone gel mg found produce total testosterone dht levels low mid high normal adult male range plasma protein binding androstanolone bound sex hormonebinding globulin albumin less corticosteroidbinding globulin circulating freely terminal halflife androstanolone circulation minutes longer testosterone minutes may account difference study transdermal androstanolone testosterone therapy reported terminal halflives hours hours androstanolone also known naturally occurring androstane steroid ketone group position hydroxyl group derivative testosterone double bond positions reduced several ester prodrugs androstanolone including androstanolone benzoate androstanolone enanthate androstanolone propionate androstanolone valerate developed introduced medical use aas conversely dihydrotestosterone acetate dihydrotestosterone butyrate dihydrotestosterone formate developed synthetic derivatives androstanolone dht developed aas androstanolone first discovered synthesized adolf butenandt first introduced medical use brand name neodrol united subsequently marketed united kingdom european transdermal androstanolone gel available france since used drug androstanolone referred androstanolone inntooltip international nonproprietary name stanolone bantooltip british approved name rather brand names androstanolone include anaboleen anabolex anaprotin uk andractim formerly androgeldht fr lu androlone apeton gelovit es neodrol ophtovital de pesomax stanaprol stanolone among availability pharmaceutical androstanolone limited available united states available certain european countries including united kingdom germany france spain italy belgium available formulations androstanolone include buccal sublingual tablets anabolex stanolone topical gels andractim gelovit ophtovital esters oil injectables like androstanolone propionate pesomax androstanolone valerate androstanolone benzoate ermaloneamp hermalone sarcosan androstanolone enanthate anaboleen depot additional androstanolone esters available medical use androstanolone esters act prodrugs androstanolone body longlasting depot effect given via intramuscular androstanolone along aas schedule iii controlled substance united states controlled substances androstanolone world antidoping agencys list prohibited therefore banned use major sports early transdermal topical androstanolone development united states treatment hypogonadism form androgen replacement therapy male osteoporosis cachexia cancer patients australia treatment benign prostatic hyperplasia reached phase ii clinical trials hypogonadism bph phase iii clinical studies cachexia development ultimately never completed indications specific although androstanolone approved cachexia country orally active synthetic derivative androstanolone oxandrolone approved used indication united topical androgens like androstanolone used studied treatment cellulite topical androstanolone abdomen also found significantly decrease subcutaneous abdominal fat women hence may useful improving body however men hyperandrogenic women higher amounts abdominal fat healthy women androgen therapy found increase abdominal fat postmenopausal women transgender httpsenwikipediaorgwikiandrostanolone